title: Rapid Communication: Cholesterol deficiency-associated APOB mutation impacts lipid metabolism in Holstein calves and breeding bulls.
abstract: During the last months, the number of reports on Holstein calves suffering from incurable idiopathic diarrhea dramatically increased. Affected calves showed severe hypocholesterolemia and mostly died within days up to a few months after birth. This new autosomal monogenic recessive inherited fat metabolism disorder, termed cholesterol deficiency (CD), is caused by a loss of function mutation of the bovine gene. The objective of the present study was to investigate specific components of lipid metabolism in 6 homozygous for the mutation (CDS) and 6 normal Holstein calves with different genotypes. Independent of sex, CDS had significantly lower plasma concentrations of total cholesterol (TC), free cholesterol (FC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), very-low-density lipoprotein cholesterol (VLDL-C), triacylglycerides (TAG), and phospholipids (PL) compared with homozygous wild-type calves ( < 0.05). Furthermore, we studied the effect of the genotype on cholesterol metabolism in adult Holstein breeding bulls of Swissgenetics. Among a total of 254 adult males, the homozygous mutant genotype was absent, 36 bulls were heterozygous carriers (CDC), and 218 bulls were homozygous wild-type (CDF). In CDC bulls, plasma concentrations of TC, FC, HDL-C, LDL-C, VLDL-C, TAG, and PL were lower compared with CDF bulls ( < 0.05). The ratios of FC:cholesteryl esters (CE) and FC:TC were higher in CDC bulls compared with CDF bulls, whereas the ratio of CE:TC was lower in CDC bulls compared with CDF bulls ( < 0.01). In conclusion, the CD-associated mutation was shown to affect lipid metabolism in affected Holstein calves and adult breeding bulls. Besides cholesterol, the concentrations of PL, TAG, and lipoproteins also were distinctly reduced in homozygous and heterozygous carriers of the mutation. Beyond malabsorption of dietary lipids, deleterious effects of apolipoprotein B deficiency on hepatic lipid metabolism, steroid biosynthesis, and cell membrane function can be expected, which may result in unspecific symptoms of reduced fertility, growth, and health.
authors.forename: J J
authors.initials: JJ
authors.lastname: Gross
authors.forename: A-C
authors.initials: AC
authors.lastname: Schwinn
authors.forename: F
authors.initials: F
authors.lastname: Schmitz-Hsu
authors.forename: F
authors.initials: F
authors.lastname: Menzi
authors.forename: C
authors.initials: C
authors.lastname: Drögemüller
authors.forename: C
authors.initials: C
authors.lastname: Albrecht
authors.forename: R M
authors.initials: RM
authors.lastname: Bruckmaier
mesh_terms: D000818:Animals; D001055:Apolipoproteins B / Q000097:blood / Q000235:genetics / Q000378:metabolism*; D002417:Cattle / Q000235:genetics* / Q000378:metabolism*; D002784:Cholesterol / Q000097:blood / Q000172:deficiency* / Q000235:genetics; D004041:Dietary Fats / Q000494:pharmacology; D005838:Genotype; D006801:Humans; D050356:Lipid Metabolism / Q000235:genetics* / Q000502:physiology; D008099:Liver / Q000378:metabolism; D008297:Male; D009154:Mutation
chemical_list: D001055:Apolipoproteins B; D004041:Dietary Fats; D002784:Cholesterol